TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biorecro AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,129
|
2,027
|
1,528 |
| Financial expenses |
164
|
418
|
2 |
| Earnings before taxes |
56
|
-710
|
-40 |
| EBITDA |
200
|
-291
|
-38 |
| Total assets |
2,564
|
1,692
|
1,272 |
| Current assets |
247
|
1,692
|
1,272 |
| Current liabilities |
1,590
|
1,135
|
716 |
| Equity capital |
78
|
22
|
556 |
| - share capital |
34
|
34
|
37 |
| Employees (average) |
4
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
3.0%
|
1.3%
|
43.7% |
| Turnover per employee |
532
|
676
|
509 |
| Profit as a percentage of turnover |
2.6%
|
-35.0%
|
-2.6% |
| Return on assets (ROA) |
8.6%
|
-17.3%
|
-3.0% |
| Current ratio |
15.5%
|
149.1%
|
177.7% |
| Return on equity (ROE) |
71.8%
|
-3227.3%
|
-7.2% |
| Change turnover |
91
|
623
|
103 |
| Change turnover % |
4%
|
44%
|
7% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.